Oramed Pharmaceuticals Inc. (NasdaqCM:ORMP) announces a share repurchase program. Under the program, the company will repurchase up to $20 million worth of its shares. The program will expired in 12 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.49 USD | 0.00% | -1.97% | +7.79% |
Jun. 26 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
Jun. 26 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.79% | 101M | |
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares.